报价延迟最少15分钟:2026/04/29 02:35 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.04 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.26/--
|
|
企业价值
22.52M
|
| 资产负债 |
|
每股账面净值
-0.06
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
52.68M
|
|
每股收益
3.26
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim. |
